Suchbegriffe: HEREDITARY CANCER, . Treffer: 8
Jahn, A; Rump, A; Widmann, TJ; Heining, C; Horak, P; Hutter, B; Paramasivam, N; Uhrig, S; Gieldon, L; Drukewitz, S; Kubler, A; Bermudez, M; Hackmann, K; Porrmann, J; Wagner, J; Arlt, M; Franke, M; Fischer, J; Kowalzyk, Z; William, D; Weth, V; Oster, S; Frohlich, M; Hullein, J; Gonzalez, CV; Kreutzfeldt, S; Mock, A; Heilig, CE; Lipka, DB; Mohrmann, L; Hanf, D; Oles, M; Teleanu, V; Allgauer, M; Ruhnke, L; Kutz, O; Knurr, A; Lassmann, A; Endris, V; Neumann, O; Penzel, R; Beck, K; Richter, D; Winter, U; Wolf, S; Pfutze, K; Georg, C; Meissburger, B; Buchhalter, I; Augustin, M; Aulitzky, WE; Hohenberger, P; Kroiss, M; Schirmacher, P; Schlenk, RF; Keilholz, U; Klauschen, F; Folprecht, G; Bauer, S; Siveke, JT; Brandts, CH; Kindler, T; Boerries, M; Illert, AL; von Bubnoff, N; Jost, PJ; Metzeler, KH; Bitzer, M; Schulze-Osthoff, K; von Kalle, C; Brors, B; Stenzinger, A; Weichert, W; Hubschmann, D; Frohling, S; Glimm, H; Schrock, E; Klink, B
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
ANN ONCOL. 2022; 33(11): 1186-1199.
Doi: 10.1016/j.annonc.2022.07.008
Web of Science
PubMed
FullText
FullText_MUG
Schaflinger, E; Enko, D
[The Impact of Next-Generation Sequencing on Medical Genetic Diagnostics and Counseling].
Dtsch Med Wochenschr. 2022; 147(20): 1336-1341.
Doi: 10.1055/a-1924-6646
Web of Science
PubMed
FullText
FullText_MUG
Sommerhäuser, G; Borgmann-Staudt, A; Schilling, R; Frey, E; Hak, J; Janhubová, V; Kepakova, K; Kepak, T; Klco-Brosius, S; Krawczuk-Rybak, M; Kruseova, J; Lackner, H; Luks, A; Michel, G; Panasiuk, A; Tamesberger, M; Vetsch, J; Balcerek, M
Health of children born to childhood cancer survivors: Participant characteristics and methods of the Multicenter Offspring Study.
CANCER EPIDEMIOL. 2021; 75: 102052
Doi: 10.1016/j.canep.2021.102052
Web of Science
PubMed
FullText
FullText_MUG
Plath, J; Siebenhofer, A; Guethlin, C; Blumenstein, I
Screening interval recommendations following a normal colonoscopy in individuals with a familial risk of colorectal cancer.
Z Gastroenterol. 2018; 56(4):361-364
Doi: 10.1055/s-0043-123882
Web of Science
PubMed
FullText
FullText_MUG
Langner, C
[Hereditary gastric and pancreatic cancer].
Pathologe. 2017; 38(3):164-169
Doi: 10.1007/s00292-017-0297-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heitzer, E; Lax, S; Lafer, I; Müller, SM; Pristauz, G; Ulz, P; Jahn, S; Högenauer, C; Petru, E; Speicher, MR; Geigl, JB
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.
BMC Med Genet. 2013; 14(1):129-129
Doi: 10.1186/1471-2350-14-129
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wölfler, A; Zebisch, A; Olipitz, W; Geigl, J; Berghold, A; Speicher, MR; Sill, H
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
J Med Genet. 2012; 49(7):422-428
Doi: 10.1136/jmedgenet-2011-100674
Web of Science
PubMed
FullText
FullText_MUG
Speicher, MR; Geigl, JB; Tomlinson, IP
Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk.
Lancet Oncol. 2010; 11(9): 890-898.
Doi: 10.1016/S1470-2045(09)70359-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar